Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01617954 · ClinicalTrials.gov registry record
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
A clinical trial, sponsored by Agendia.
- Completed
- Registry status
- 820
- Enrollment target
NCT01617954 is a clinical trial that has completed, run by Agendia. The registered enrollment target is 820 participants.
The verdict
NCT01617954 has completed, sponsored by Agendia.
- COMPLETED
- Registry status
- 820 participants
- Enrollment target
Study Summary
This is a prospective study that will assess the impact of MammaPrint on chemotherapy + endocrine versus endocrine alone treatment decisions in patients with an Oncotype Intermediate Score.
Interventions
- DEVICE MammaPrint
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 820 participants |
| Start Date | 2012-05 |
| Est. Completion | 2015-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01617954
The ClinicalTrials.gov registry entry for NCT01617954 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 820 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Agendia, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MammaPrint is the first listed.
NCT01617954 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01617954 about?
NCT01617954 is a clinical study titled "PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score". This is a prospective study that will assess the impact of MammaPrint on chemotherapy + endocrine versus endocrine alone treatment decisions in patients with an Oncotype Intermediate Score.
What is the current status of trial NCT01617954?
This trial is currently completed. The enrollment target is 820 participants. The study started on 2012-05. Estimated completion is 2015-12.
What interventions are being tested in trial NCT01617954?
The interventions under investigation include: MammaPrint (DEVICE).
Who is sponsoring clinical trial NCT01617954?
This trial is sponsored by Agendia, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.